Author
Listed:
- Swayam Prakash Srivastava
(Yale University School of Medicine New Haven
Yale University School of Medicine New Haven
Kanazawa Medical University)
- Han Zhou
(Yale University School of Medicine New Haven
Yale University School of Medicine New Haven)
- Ocean Setia
(Yale University School of Medicine New Haven
Yale University School of Medicine New Haven)
- Bing Liu
(Yale University School of Medicine New Haven
Yale University School of Medicine New Haven)
- Keizo Kanasaki
(Kanazawa Medical University)
- Daisuke Koya
(Kanazawa Medical University)
- Alan Dardik
(Yale University School of Medicine New Haven
Yale University School of Medicine New Haven
VA Connecticut Healthcare System)
- Carlos Fernandez-Hernando
(Yale University School of Medicine New Haven
Yale University School of Medicine New Haven
Yale University School of Medicine New Haven
Yale University School of Medicine New Haven)
- Julie Goodwin
(Yale University School of Medicine New Haven
Yale University School of Medicine New Haven)
Abstract
Endothelial cells play a key role in the regulation of disease. Defective regulation of endothelial cell homeostasis may cause mesenchymal activation of other endothelial cells or neighboring cell types, and in both cases contributes to organ fibrosis. Regulatory control of endothelial cell homeostasis is not well studied. Diabetes accelerates renal fibrosis in mice lacking the endothelial glucocorticoid receptor (GR), compared to control mice. Hypercholesterolemia further enhances severe renal fibrosis. The fibrogenic phenotype in the kidneys of diabetic mice lacking endothelial GR is associated with aberrant cytokine and chemokine reprogramming, augmented Wnt signaling and suppression of fatty acid oxidation. Both neutralization of IL-6 and Wnt inhibition improve kidney fibrosis by mitigating mesenchymal transition. Conditioned media from endothelial cells from diabetic mice lacking endothelial GR stimulate Wnt signaling-dependent epithelial-to-mesenchymal transition in tubular epithelial cells from diabetic controls. These data demonstrate that endothelial GR is an essential antifibrotic molecule in diabetes.
Suggested Citation
Swayam Prakash Srivastava & Han Zhou & Ocean Setia & Bing Liu & Keizo Kanasaki & Daisuke Koya & Alan Dardik & Carlos Fernandez-Hernando & Julie Goodwin, 2021.
"Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy,"
Nature Communications, Nature, vol. 12(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22617-y
DOI: 10.1038/s41467-021-22617-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22617-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.